Internal contamination of laboratory personnel by 131I1.
Internal contamination by 131I among the personnel in a nuclear medicine laboratory was surveyed from January to July, 1979. Because of the formulation change made by the manufacturer in April to reduce volatility, it was possible to study two different therapeutic solutions of 131I. Internal contamination of personnel who administered 131I was found to be 90 times less after the reformulation. Compliance with a recent NRC regulatory guide of less than 40 nCi (1.48 kB1) of 131I thyroid burden as a quarterly average should not be difficult using the new, less volatile 131I; however, strict precautionary measures are essential to minimize contamination, which is common in the nuclear medicine environment.[1]References
- Internal contamination of laboratory personnel by 131I1. Nishiyama, H., Lukes, S.J., Mayfield, G., Grossman, L.W. Radiology. (1980) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Use
The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.








